| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
1996-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
1998-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H10506640-A |
| titleOfInvention |
Use of ribavirin and interferon alpha for the treatment of hepatitis C |
| abstract |
(57) [Summary]nDisclosed are methods for treating chronic hepatitis C infection in a patient in need of such treatment. The method comprises combining an effective amount of α-interferon for treating chronic hepatitis C infection with an effective amount of ribavirin for the treatment without or with the side effects associated with the administration of ribavirin and α-interferon. And administering the drug. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007013677-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006033453-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002527522-A |
| priorityDate |
1995-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |